138 related articles for article (PubMed ID: 14729102)
1. Selected amino acids, dipeptides and arylalkylamine derivatives do not act as allosteric modulators at GABAB receptors.
Urwyler S; Gjoni T; Kaupmann K; Pozza MF; Mosbacher J
Eur J Pharmacol; 2004 Jan; 483(2-3):147-53. PubMed ID: 14729102
[TBL] [Abstract][Full Text] [Related]
2. Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501.
Urwyler S; Mosbacher J; Lingenhoehl K; Heid J; Hofstetter K; Froestl W; Bettler B; Kaupmann K
Mol Pharmacol; 2001 Nov; 60(5):963-71. PubMed ID: 11641424
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties.
Urwyler S; Gjoni T; Koljatić J; Dupuis DS
Neuropharmacology; 2005 Mar; 48(3):343-53. PubMed ID: 15721166
[TBL] [Abstract][Full Text] [Related]
4. Effects of intraperitoneal administration of the GABAB receptor positive allosteric modulator 2,6-di tert-butyl-4-(2-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) on food intake in non-deprived rats.
Ebenezer IS
Eur J Pharmacol; 2012 Sep; 690(1-3):115-8. PubMed ID: 22652431
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of metabotropic GABAB receptors by L-amino acids and dipeptides in rat neocortex.
Kerr DI; Ong J
Eur J Pharmacol; 2003 May; 468(2):103-8. PubMed ID: 12742517
[TBL] [Abstract][Full Text] [Related]
6. GABA(B) receptor modulators potentiate baclofen-induced depression of dopamine neuron activity in the rat ventral tegmental area.
Chen Y; Phillips K; Minton G; Sher E
Br J Pharmacol; 2005 Apr; 144(7):926-32. PubMed ID: 15711597
[TBL] [Abstract][Full Text] [Related]
7. Positive regulation of GABA(B) receptors dually coupled to cyclic AMP by the allosteric agent CGP7930.
Onali P; Mascia FM; Olianas MC
Eur J Pharmacol; 2003 Jun; 471(2):77-84. PubMed ID: 12818694
[TBL] [Abstract][Full Text] [Related]
8. COR758, a negative allosteric modulator of GABA
Porcu A; Mostallino R; Serra V; Melis M; Sogos V; Beggiato S; Ferraro L; Manetti F; Gianibbi B; Bettler B; Corelli F; Mugnaini C; Castelli MP
Neuropharmacology; 2021 May; 189():108537. PubMed ID: 33798546
[TBL] [Abstract][Full Text] [Related]
9. Allosteric modulation of GABA(B) receptor function in human frontal cortex.
Olianas MC; Ambu R; Garau L; Onali P
Neurochem Int; 2005 Jan; 46(2):149-58. PubMed ID: 15627515
[TBL] [Abstract][Full Text] [Related]
10. Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice.
Kaupmann K; Cryan JF; Wellendorph P; Mombereau C; Sansig G; Klebs K; Schmutz M; Froestl W; van der Putten H; Mosbacher J; Bräuner-Osborne H; Waldmeier P; Bettler B
Eur J Neurosci; 2003 Nov; 18(10):2722-30. PubMed ID: 14656321
[TBL] [Abstract][Full Text] [Related]
11. N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function.
Urwyler S; Pozza MF; Lingenhoehl K; Mosbacher J; Lampert C; Froestl W; Koller M; Kaupmann K
J Pharmacol Exp Ther; 2003 Oct; 307(1):322-30. PubMed ID: 12954816
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo pharmacological characterization of SSD114, a novel GABAB positive allosteric modulator.
Porcu A; Lobina C; Giunta D; Solinas M; Mugnaini C; Castelli MP
Eur J Pharmacol; 2016 Nov; 791():115-123. PubMed ID: 27578262
[TBL] [Abstract][Full Text] [Related]
13. The GABA
Olianas MC; Dedoni S; Onali P
Eur J Pharmacol; 2017 Jan; 794():135-146. PubMed ID: 27876620
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological actions of oximino-propofol analogues at GABA(B) autoreceptors.
Parker DA; Marino V; Sullivan T; Ong J; Khalafy J; Badali M; Rimaz M; Prager RH
Clin Exp Pharmacol Physiol; 2011 Apr; 38(4):203-7. PubMed ID: 21255061
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).
Perdona' E; Costantini VJ; Tessari M; Martinelli P; Carignani C; Valerio E; Mok MH; Zonzini L; Visentini F; Gianotti M; Gordon L; Rocheville M; Corsi M; Capelli AM
Neuropharmacology; 2011; 61(5-6):957-66. PubMed ID: 21756923
[TBL] [Abstract][Full Text] [Related]
16. Arylalkylamines are a novel class of positive allosteric modulators at GABA(B) receptors in rat neocortex.
Kerr DI; Ong J; Puspawati NM; Prager RH
Eur J Pharmacol; 2002 Sep; 451(1):69-77. PubMed ID: 12223231
[TBL] [Abstract][Full Text] [Related]
17. Characterization of (R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one as a positive allosteric modulator of GABAB receptors.
Malherbe P; Masciadri R; Norcross RD; Knoflach F; Kratzeisen C; Zenner MT; Kolb Y; Marcuz A; Huwyler J; Nakagawa T; Porter RH; Thomas AW; Wettstein JG; Sleight AJ; Spooren W; Prinssen EP
Br J Pharmacol; 2008 Jun; 154(4):797-811. PubMed ID: 18536733
[TBL] [Abstract][Full Text] [Related]
18. GABAB receptor-positive modulators: enhancement of GABAB receptor agonist effects in vivo.
Koek W; France CP; Cheng K; Rice KC
J Pharmacol Exp Ther; 2010 Oct; 335(1):163-71. PubMed ID: 20628000
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of GABAB receptor subtypes assembled with auxiliary KCTD subunits.
Rajalu M; Fritzius T; Adelfinger L; Jacquier V; Besseyrias V; Gassmann M; Bettler B
Neuropharmacology; 2015 Jan; 88():145-54. PubMed ID: 25196734
[TBL] [Abstract][Full Text] [Related]
20. Influence of positive allosteric modulators on GABA(B) receptor coupling in rat brain: a scintillation proximity assay characterisation of G protein subtypes.
Mannoury la Cour C; Herbelles C; Pasteau V; de Nanteuil G; Millan MJ
J Neurochem; 2008 Apr; 105(2):308-23. PubMed ID: 18021295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
